Passer au contenu principal

Iron-871

#871

USP

Regulatory status

FS

Category

Potential Use

EMACRIT IN THE TREATMENT OF ANEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE

Indications / Claims

Iron Deficiency Anemia (IDA)
IDA in specific patients: women, elderly
Support to er EMACRIT increased hemoglobin by 2.5 points
EMACRIT increased transferrin saturation by 7 points
EMACRIT showed no adverse events of any kind in any patient

Request a quote or information?




    *Mandatory field